Now PlayingEP. 1 Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma
Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell LymphomaByMary CaffreyFebruary 6th 2026
Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026ByRose McNultyFebruary 6th 2026
Linking Community Screening Programs to Cancer Centers Boosts Trial Diversity: Susan Vadaparampil, PhD, MPH ByBrooke McCormick,Susan Vadaparampil, PhD, MPHFebruary 6th 2026
Quality of Life: The Pending Outcome in Idiopathic Pulmonary FibrosisByFranco Nicolae Grados RodriguezFebruary 6th 2026